• No tags were found...

ATB 15.03.2013.pdf - Portal SSIF Broker

• With almost 6 decades of tradition in the Romanian pharma

sector, ATB manufactures over 150 medicines, used for the

treatment of several diseases (infectious, dermatology,

cardiovascular, digestive and musculoskeletal);

• At the same time, ATB is an important producer of Nystatin,

with a global market share of 35%;

• Listed on Bucharest Stock Exchange since 1997, the main

shareholder is the Romanian Government (53%);

• The turnover rose at CAGR 10% during the period 2003-

2012, to RON 297mn;

• Over the past years ATB focused on the internationalisation:

the volume of exports rose from USD 13.2mn in 2009 to USD

20mn in 2012 and the management expects an increase to

USD 23.5mn in 2013.


More magazines by this user
Similar magazines